1. Evaluation of cell mediated immunity in advanced pancreatic carcinoma before and after treatment with interleukin-2 (IL-2);Abdel-Wahab;Hepatogastroenterology,1999
2. Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: a gene therapy approach;Albini;Am. J. Pathol.,2000
3. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte–macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants;Allione;Cancer Res.,1994
4. Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration;Andersen;Semin. Cancer Biol.,2003
5. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo;Angiolillo;J. Exp. Med.,1995